The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 18, 2026
Snapshot (as of Jul 18, 2026): Johnson & Johnson (JNJ) pays a $5.24 annual dividend ($1.34 quarterly), yielding 2.07% at $253.04/share. Next ex-dividend date 2026-08-25. 62+ consecutive years of dividend growth (Dividend King). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.07%
Annual Dividend: $5.24 per share
Payout Ratio: 59.5%
Ex-Dividend Date: 2026-08-25
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 65
Johnson & Johnson is a Dividend King with 62 consecutive years of dividend increases, operating across pharmaceuticals and medical devices through its Innovative Medicine and MedTech segments. The current dividend yield sits at 1.99%, with JNJ paying $5.24 per share annually in quarterly installments. The next ex-dividend date is May 26, 2026, and the last declared quarterly payment was $1.34 per share. With a beta of 0.235, JNJ stock moves far less than the broader market, making it a fit for income investors who prioritize low volatility over high yield.
Johnson & Johnson pays out 59.5% of earnings as dividends, a payout ratio classified as moderate (40-60%). That level leaves a meaningful buffer of retained earnings, supported by JNJ's operations across two large healthcare segments: Innovative Medicine, which spans oncology, immunology, and cardiovascular therapies, and MedTech, which covers orthopaedics, surgery, and vision products. Johnson & Johnson dividend safety benefits from this breadth, as the company is not dependent on a single product category. The primary pressure point is the payout ratio sitting near the upper boundary of the moderate range, leaving less room to absorb an earnings decline than a lower ratio would.
Johnson & Johnson dividend history shows a CAGR of 6.1% per year from 2011 to 2025. The per-share payment grew from $2.25 to $5.14 over that period (2026 is a partial year and excluded from the growth calculation). The smallest annual increase in the window was 4.5% in 2024, which sets a realistic floor for what JNJ's recent growth pace looks like at its most modest.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +4.9% | $4.45 (2022) | $5.14 (2025) |
| 5-Year | +5.2% | $3.98 (2020) | $5.14 (2025) |
| 10-Year | +5.7% | $2.95 (2015) | $5.14 (2025) |
Johnson & Johnson fits dividend investors who want a healthcare-sector payer with a long, unbroken increase streak rather than a high current yield. The yield is low (below 2%), and at 1.99% it sits above the 5-year average of 1.78%, so current buyers are getting a slightly better entry yield than the recent norm. As a Dividend King with 62 consecutive years of increases spanning immunology drugs, surgical devices, and vision products, JNJ offers one of the longest dividend growth records available. The trade-off is straightforward: income investors accept a sub-2% yield in exchange for a payout that has never been cut within the available data window and has grown at 6.1% annually over 14 years.
JNJ is a Dividend King — 62 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-05-26 | $1.3400 |
| 2026-02-24 | $1.3000 |
| 2025-11-25 | $1.3000 |
| 2025-08-26 | $1.3000 |
| 2025-05-27 | $1.3000 |
| 2025-02-18 | $1.2400 |
| 2024-11-26 | $1.2400 |
| 2024-08-27 | $1.2400 |
| 2024-05-20 | $1.2400 |
| 2024-02-16 | $1.1900 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.6400 |
| 2025 | $5.1400 |
| 2024 | $4.9100 |
| 2023 | $4.7000 |
| 2022 | $4.4500 |
Project income from JNJ with the JNJ dividend calculator or track your full portfolio with the dividend tracker.